Cancer News and Research

Latest Cancer News and Research

McLaren Health Care and ProTom partner to bring Proton beam therapy to Michigan

Cancer patients residing in and near Michigan are one step closer to receiving one of the most advanced forms of treatment available with a new partnership being formed between McLaren Health Care and ProTom International, a Texas-based health care technology company.

23 Sep 2009

Patient recruitment completed for crucial glioblastoma study

MagForce Nanotechnologies AG (FWB:MF6) has successfully completed patient recruitment for its study on recurrent glioblastoma, which is of critical importance for demonstrating the efficacy of its proprietary Nano-Cancer® therapy.

23 Sep 2009

FCI to educate women about fertility preservation

Life-saving cancer treatments such as chemotherapy and radiation can destroy the reproductive potential of both men and women; an added struggle for the 130,000 people in the US diagnosed with cancer each year. The good news is that advances in fertility technologies now give patients the ability to preserve their fertility prior to treatment, an option many oncologists fail to inform their patients.

23 Sep 2009

Gamma Medica-Ideas closes $24 million financing to support digital technologies

Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it had closed a $24 million financing, the company's first institutional round, in order to support continued growth of the company's proprietary digital SPECT, PET and CT technologies in current and new markets.

23 Sep 2009

Oncology Metrics and Altos Solutions to merge

Altos Solutions and Oncology Metrics llc, today announced the planned merger of the two companies, creating a combined technology and knowledge data company serving community-based oncology practices. The merged company will be known as Altos Solutions and will be headquartered in Los Altos, California.

23 Sep 2009

Obesity can increase cancer incidence in leukemic children

Obesity is an important factor contributing to chemotherapy resistance and increasing relapse rates among children with leukemia, according to recent findings published online first in Cancer Research, a journal of the American Association for Cancer Research.

23 Sep 2009

HealthRock to promote health education

The $1 trillion cost and massive government role envisioned by the Obama Administration’s health care reform plan (The Affordable Health Choices Act of 2009) continue to create controversy in Congress and throughout the nation.

23 Sep 2009

$1.2 million grant to study centrosomes and cilia and their connections to human disease

If you don't know how a human cell is supposed to work, it's hard to offer a good explanation when the cell goes haywire -- as it does in cancer. That's why a Florida State University College of Medicine researcher has been awarded a $1.2 million grant to explore the role of centrosomes and cilia in cell division and development and their connections to human disease.

22 Sep 2009

Advaxis' patent approval enables the development of new vaccines with additional properties

The United States Patent and Trademark Office (USPTO) has granted and issued Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, patent 7,588,930 “Compositions and Methods for Enhancing Immunogenicity of Antigens.” This patent expands the Company’s intellectual property portfolio to cover another family of adjuvant proteins based upon the Lm protein Act-A.

22 Sep 2009

Oncotype DX Recurrence Score provides consistent results across varied patient populations

Genomic Health, Inc. today, announced results from the first study to compare the distribution of Oncotype DX® Recurrence Score® results between European, Middle Eastern and United States patient populations.

22 Sep 2009

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast cancer that met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.

22 Sep 2009

Cancer Research UK invests £16 million in new Drug Discovery Programes at Manchester and Glasgow

CANCER RESEARCH UK is set to extend its drug discovery effort by investing up to £16 million in two new Drug Discovery Programmes at the Paterson Institute for Cancer Research in Manchester and the Beatson Institute for Cancer Research in Glasgow.

22 Sep 2009

Carolinas HealthCare System implements Radware's application delivery solutions to prevent network downtime

Radware (Nasdaq: RDWR), the leading provider of integrated application delivery solutions for business-smart networking, today announced that Carolinas HealthCare System (CHS), the largest healthcare system in North and South Carolina, has leveraged Radware's suite of application delivery solutions in an effort to maintain a secure network environment with advanced load balancing capabilities for its extensive hospital system.

22 Sep 2009

Study reveals effectiveness of targeted heat therapy in addition to chemotherapy

Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.

22 Sep 2009

Hormone therapy for treating prostate cancer is linked to heart problems

Berlin, Germany: New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems. Some choices of therapy appear, however, to be less risky than others.

22 Sep 2009

Employees of Vertex Pharmaceuticals take part in volunteer activities

Vertex Pharmaceuticals Incorporated today announced that approximately 800 employees took part in Vertex’s first companywide Day of Service, which was held on Friday, September 18, 2009.

22 Sep 2009

Beech Sandal Company supports breast cancer awareness program

Beech Sandal Company declares its commitment to raising awareness and funding for education, research and treatment for women's health issues by donating its popular, health-oriented Yoga Sandals(R) footwear and a portion of the company's sales to support a number of worthy causes.

22 Sep 2009

Breast Cancer Action launches "Milking Cancer" campaign against Eli Lilly

Breast Cancer Action (BCA), known as the watchdog of the breast cancer movement, today announced the launch of their "Milking Cancer" campaign challenging the pharmaceutical giant Eli Lilly to stop manufacturing rBGH. rBGH (recombinant bovine growth hormone, also known as rBST) has long been linked to cancer.

22 Sep 2009

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.

22 Sep 2009

Drug registration process for Nutra Pharma's pain reliever begins

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.

22 Sep 2009

Cancer News and Research

Latest Cancer News and Research

McLaren Health Care and ProTom partner to bring Proton beam therapy to Michigan

Patient recruitment completed for crucial glioblastoma study

FCI to educate women about fertility preservation

Gamma Medica-Ideas closes $24 million financing to support digital technologies

Oncology Metrics and Altos Solutions to merge

Obesity can increase cancer incidence in leukemic children

HealthRock to promote health education

$1.2 million grant to study centrosomes and cilia and their connections to human disease

Advaxis' patent approval enables the development of new vaccines with additional properties

Oncotype DX Recurrence Score provides consistent results across varied patient populations

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Cancer Research UK invests £16 million in new Drug Discovery Programes at Manchester and Glasgow

Carolinas HealthCare System implements Radware's application delivery solutions to prevent network downtime

Study reveals effectiveness of targeted heat therapy in addition to chemotherapy

Hormone therapy for treating prostate cancer is linked to heart problems

Employees of Vertex Pharmaceuticals take part in volunteer activities

Beech Sandal Company supports breast cancer awareness program

Breast Cancer Action launches "Milking Cancer" campaign against Eli Lilly

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

Drug registration process for Nutra Pharma's pain reliever begins

Understanding the DNA Damage Response in Innate Immunity eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in